World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
95
Citations
30455
World Ranking
906
National Ranking
81

Medicine

D-Index
96
Citations
30660
World Ranking
9756
National Ranking
949

John D. Isaacs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Isaacs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 554 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John D. Isaacs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Isaacs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1974 - Member of the National Academy of Sciences

Overview

John D. Isaacs is a researcher affiliated with Newcastle University in the United Kingdom, with a focus on medicine and more specifically rheumatology. Their work covers various subfields including immunology, hematology, radiology, nuclear medicine and imaging, and genetics. Their research spans a variety of topics related to immune-mediated and inflammatory diseases.

Isaacs has contributed extensively to the study of rheumatoid arthritis and other autoimmune disorders. Some of the main topics of their work include:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research
  • Biosimilars and Bioanalytical Methods
  • Chronic Lymphocytic Leukemia Research
  • T-cell and B-cell Immunology

Isaacs' recent publications demonstrate research activity in clinical trials, treatment consensus, and biomarker analysis. Notable papers include:

  • "Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial" (2021, The Lancet)
  • "Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement" (2020, Annals of the Rheumatic Diseases)
  • "EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2" (2020, Annals of the Rheumatic Diseases)
  • "Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial" (2022, Nature Medicine)
  • "Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis" (2020, Nature Communications)

Their frequent co-authors include:

  • Arthur G. Pratt
  • Anne Barton
  • Ann W. Morgan
  • Kimme L Hyrich
  • Darren Plant

Isaacs has published in multiple journals with repeated contributions to:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology
  • RMD Open
  • Arthritis & Rheumatology

Isaacs' research portfolio includes over 300 publications in medicine, with a significant focus on rheumatology as represented by 129 publications in that subfield. Other notable subfields include immunology and hematology.

Isaacs was recognized with the award of Member of the National Academy of Sciences in 1974.

Best Publications

  • The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.

    Richard J. Wakefield;Wayne W. Gibbon;Philip G. Conaghan;Philip O'Connor

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

    Wan Fai Ng;Phillip J. Duggan;Frederique Ponchel;Giuseppe Matarese

  • Cytokines in rheumatoid arthritis - shaping the immunological landscape.

    Iain B. McInnes;Christopher D. Buckley;John D. Isaacs

  • Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

    M.H. Buch;J.S. Smolen;N. Betteridge;F.C. Breedveld

  • Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions

    Frederique Ponchel;Carmel Toomes;Kieran Bransfield;Fong T Leong

  • Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

    Iain B. McInnes;Joachim Sieper;Juergen Braun;Paul Emery

  • Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.

    Joel Kremer;Zhan-Guo Li;Stephen Hall;Roy Fleischmann

  • Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study

    Joanna Collerton;Carmen Martin-Ruiz;Karen Davies;Catharien M. Hilkens

  • Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis

    Philip G. Conaghan;Philip O'Connor;Dennis McGonagle;Paul Astin

  • Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

    Paul Emery;A. Deodhar;W. F. Rigby;J. D. Isaacs

  • Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells

    Muzlifah A. Haniffa;Xiao-Nong Wang;Udo Holtick;Michelle Rae

  • Integrated safety in tocilizumab clinical trials.

    Michael H Schiff;Joel M Kremer;Angelika Jahreis;Emma Vernon

  • Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers

    Philip M. Brown;Arthur G. Pratt;John D. Isaacs

  • Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?

    Kenneth F Baker;John D Isaacs;John D Isaacs

  • Humanised monoclonal antibody therapy for rheumatoid arthritis.

    J D Isaacs;R A Watts;B L Hazleman;G Hale

  • Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

    Mark G. Wing;Thibault Moreau;Judith Greenwood;Richard M. Smith

  • Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Unknown

  • Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis

    G M Bell;A E Anderson;J Diboll;R Reece

  • Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood

    C. A. Lawson;A. K. Brown;V. Bejarano;S. H. Douglas

  • Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

    C Potter;K L Hyrich;A Tracey;M Lunt

  • Biologic therapies in rheumatology: lessons learned, future directions

    Vibeke Strand;Robert Kimberly;John D. Isaacs

Frequent Co-Authors

Ann W. Morgan
Ann W. Morgan University of Leeds
Anne Barton
Anne Barton University of Manchester
Paul Emery
Paul Emery University of Leeds
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Catharien M. U. Hilkens
Catharien M. U. Hilkens Newcastle University
Herman Waldmann
Herman Waldmann University of Oxford
Iain B. McInnes
Iain B. McInnes University of Glasgow
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Andrew Filer
Andrew Filer University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open up diverse career opportunities. Those looking for practical entry points into healthcare may consider LPN programs. Identifying the best easiest lpn programs to get into can help beginners start their careers efficiently while gaining essential patient care skills.

Advancing further, nurse practitioner degrees offer specialized clinical roles. If flexibility and program accessibility are priorities, knowing which nurse practitioner program is easiest can be valuable for choosing the right path without compromising quality education.

Mental health is a growing area within healthcare where Immunology and psychiatry intersect, particularly in research on neuroimmunology. For those interested in clinical practice, exploring the best online psychiatric mental health nurse practitioner programs provides options with strong clinical placement support.

Cost is often a critical factor in education decisions. Students can find affordable training by reviewing cheap psych np programs that offer quality coursework without excessive financial burdens.

Best Scientists Citing John D. Isaacs

Trending Scientists

Recently Published Articles